Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

75 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A culturally tailored personaliseD nutrition intErvention in South ASIan women at risk of Gestational Diabetes Mellitus (DESI-GDM): a randomised controlled trial protocol.
Stennett RN, Adamo KB, Anand SS, Bajaj HS, Bangdiwala SI, Desai D, Gerstein HC, Kandasamy S, Khan F, Lear SA, McDonald SD, Pocsai T, Ritvo P, Rogge A, Schulze KM, Sherifali D, Stearns JC, Wahi G, Williams NC, Zulyniak MA, de Souza RJ. Stennett RN, et al. Among authors: bajaj hs. BMJ Open. 2023 May 2;13(5):e072353. doi: 10.1136/bmjopen-2023-072353. BMJ Open. 2023. PMID: 37130668 Free PMC article.
Pharmacologic Glycemic Management of Type 2 Diabetes in Adults: 2020 Update - The User's Guide.
Diabetes Canada Clinical Practice Guidelines Steering Committee; Senior PA, Houlden RL, Kim J, Mackay D, Nagpal S, Rabi D, Sherifali D, Bajaj HS. Diabetes Canada Clinical Practice Guidelines Steering Committee, et al. Among authors: bajaj hs. Can J Diabetes. 2020 Oct;44(7):592-596. doi: 10.1016/j.jcjd.2020.08.002. Can J Diabetes. 2020. PMID: 32972641 Review. No abstract available.
Erectile function in men with type 2 diabetes treated with dulaglutide: an exploratory analysis of the REWIND placebo-controlled randomised trial.
Bajaj HS, Gerstein HC, Rao-Melacini P, Basile J, Colhoun H, Conget I, Cushman WC, Dagenais GR, Franek E, Hanefeld M, Keltai M, Lakshmanan M, Lanas F, Leiter LA, Lopez-Jaramillo P, Pirags V, Pogosova N, Probstfield J, Raubenheimer P, Ryden L, Shaw JE, Sheu WH, Xavier D. Bajaj HS, et al. Lancet Diabetes Endocrinol. 2021 Aug;9(8):484-490. doi: 10.1016/S2213-8587(21)00115-7. Epub 2021 Jun 18. Lancet Diabetes Endocrinol. 2021. PMID: 34153269 Clinical Trial.
Blood Glucose Monitoring in Adults and Children with Diabetes: Update 2021.
Diabetes Canada Clinical Practice Guidelines Expert Working Group; Cheng AYY, Feig DS, Ho J, Siemens R; Diabetes Canada Clinical Practice Guidelines Steering Committee. Diabetes Canada Clinical Practice Guidelines Expert Working Group, et al. Can J Diabetes. 2021 Oct;45(7):580-587. doi: 10.1016/j.jcjd.2021.07.003. Can J Diabetes. 2021. PMID: 34511234 No abstract available.
Comparing a daily versus weekly titration algorithm in people with type 2 diabetes switching from basal insulin to iGlarLixi in the LixiLan ONE CAN randomized trial.
Hramiak I, Gerstein HC, Leiter LA, Yale JF, Bajaj HS, Stewart J, Toutounji MJ, Harris SB. Hramiak I, et al. Among authors: bajaj hs. Diabetes Obes Metab. 2022 Oct;24(10):1998-2007. doi: 10.1111/dom.14787. Epub 2022 Jun 29. Diabetes Obes Metab. 2022. PMID: 35670659 Free PMC article. Clinical Trial.
Randomized Comparison of Initiating the Fixed-Ratio Combination of iGlarLixi or Biosimilar Insulin Glargine Together With Gliclazide in Participants of South Asian Origin With Type 2 Diabetes: VARIATION 2 SA Trial.
Bajaj HS, Chu L, Bansal N, Brown RE, Dhillon G, Gupta R, Bhela JS, Padda JK, Khandwala H, Venn K, Aronson R. Bajaj HS, et al. Can J Diabetes. 2022 Jul;46(5):495-502. doi: 10.1016/j.jcjd.2022.02.003. Epub 2022 Feb 11. Can J Diabetes. 2022. PMID: 35752566 Clinical Trial.
Remission of Type 2 Diabetes: Diabetes Canada Clinical Practice Guidelines Expert Working Group.
MacKay D, Chan C, Dasgupta K, Dominy C, Gagner M, Jin S, Kim J, Little JP, MacDonald B, McInnes N, Reichert S, Bajaj HS; Diabetes Canada Clinical Practice Guidelines Steering Committee:; Bajaj HS, Gilbert J, Houlden R, Kim J, MacDonald B, MacKay D, Mansell K, Rabi D, Senior P, Sherifali D. MacKay D, et al. Among authors: bajaj hs. Can J Diabetes. 2022 Dec;46(8):753-761.e8. doi: 10.1016/j.jcjd.2022.10.004. Epub 2022 Nov 11. Can J Diabetes. 2022. PMID: 36567079 No abstract available.
Remission of Type 2 Diabetes: User's Guide: Diabetes Canada Clinical Practice Guidelines Expert Working Group.
Jin S, Bajaj HS, Brazeau AS, Champagne J, MacDonald B, MacKay D, Reichert SM, Vallis M; Diabetes Canada Clinical Practice Guidelines Steering Committee:; Bajaj HS, Gilbert J, Houlden R, Kim J, MacDonald B, MacKay D, Mansell K, Rabi D, Senior P, Sherifali D. Jin S, et al. Among authors: bajaj hs. Can J Diabetes. 2022 Dec;46(8):762-774. doi: 10.1016/j.jcjd.2022.10.005. Epub 2022 Nov 11. Can J Diabetes. 2022. PMID: 36567080 No abstract available.
75 results